Marie Duhamel

1.0k total citations
36 papers, 538 citations indexed

About

Marie Duhamel is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Marie Duhamel has authored 36 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Immunology and 6 papers in Oncology. Recurrent topics in Marie Duhamel's work include Immune cells in cancer (8 papers), Ubiquitin and proteasome pathways (6 papers) and Advanced Proteomics Techniques and Applications (5 papers). Marie Duhamel is often cited by papers focused on Immune cells in cancer (8 papers), Ubiquitin and proteasome pathways (6 papers) and Advanced Proteomics Techniques and Applications (5 papers). Marie Duhamel collaborates with scholars based in France, Lebanon and United States. Marie Duhamel's co-authors include Michel Salzet, Isabelle Fournier, Firas Kobeissy, Soulaimane Aboulouard, Franck Rodet, Maxence Wisztorski, Tristan Cardon, A. Decoster, Didier Hober and Antonella Raffo‐Romero and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Marie Duhamel

33 papers receiving 525 citations

Peers

Countries citing papers authored by Marie Duhamel

Since Specialization

Citations

This map shows the geographic impact of Marie Duhamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Duhamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Duhamel more than expected).

Fields of papers citing papers by Marie Duhamel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Duhamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Duhamel. The network helps show where Marie Duhamel may publish in the future.

Co-authorship network of co-authors of Marie Duhamel

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Duhamel. A scholar is included among the top collaborators of Marie Duhamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Duhamel. Marie Duhamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protocol for generating a co-culture of macrophages with breast cancer tumoroids 2024 ·STAR Protocols ·Antonella Raffo‐Romero, (unknown), Nawale Hajjaji, Michel Salzet, Marie Duhamel	2
2	Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities 2024 ·Cell Death and Disease ·(unknown), Antonella Raffo‐Romero, Nawale Hajjaji, Firas Kobeissy, (unknown), Soulaimane Aboulouard, (unknown), Suman Mitra, Isabelle Fournier, (unknown), Michel Salzet, Marie Duhamel	8
3	Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management 2024 ·Cell Reports Medicine ·(unknown), (unknown), (unknown), Claude Alain Maurage, Pierre Tirilly, Émilie Le Rhun, Bertrand Meresse, Gargey Yagnik, Mark J. Lim, Kenneth J. Rothschild, Marie Duhamel, Michel Salzet, Isabelle Fournier	16
4	A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses 2024 ·Cell Reports Methods ·Antonella Raffo‐Romero, (unknown), Sophie Salomé‐Desnoulez, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel	14
5	Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis 2023 ·Cell Death and Disease ·Maxence Wisztorski, Soulaimane Aboulouard, (unknown), Marie Duhamel, Philippe Saudemont, Tristan Cardon, Fabrice Narducci, Y Robin, (unknown), (unknown), Nawale Hajjaji, Firas Kobeissy, Éric Leblanc, Isabelle Fournier, Michel Salzet	8
6	Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome 2023 ·Cell Death and Disease ·(unknown), (unknown), Tristan Cardon, (unknown), Soulaimane Aboulouard, Antonella Raffo‐Romero, Marie Duhamel, (unknown), Marco Trerotola, David Devos, Firas Kobeissy, Fabien Vanden Abeele, Amélie Bonnefond, Isabelle Fournier, Franck Rodet, Michel Salzet	4
7	Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion 2023 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Soulaimane Aboulouard, Estelle Laurent, Étienne Coyaud, Antonella Raffo‐Romero, Marie Duhamel, Amélie Bonnefond, Mehdi Derhourhi, Marco Trerotola, Ikram El Yazidi‐Belkoura, David Devos, Monika Žilková, Firas Kobeissy, Fabien Vanden Abeele, Isabelle Fournier, (unknown), Franck Rodet, Michel Salzet	8
8	Establishment and characterization of canine mammary tumoroids for translational research 2023 ·BMC Biology ·Antonella Raffo‐Romero, Soulaimane Aboulouard, Emmanuel Bouchaert, Agata Rybicka, Dominique Tierny, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel	7
9	Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival 2022 ·Nature Communications ·Marie Duhamel, (unknown), Maxence Wisztorski, Soulaimane Aboulouard, Jean‐Pascal Gimeno, Nina Ogrinc, Patrick Devos, Tristan Cardon, Michael Weller, Fabienne Escande, Fahed Zaïri, Claude‐Alain Maurage, Émilie Le Rhun, Isabelle Fournier, Michel Salzet	36
10	In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer 2021 ·Cell Reports Medicine ·Soulaimane Aboulouard, Maxence Wisztorski, Marie Duhamel, Philippe Saudemont, Tristan Cardon, Fabrice Narducci, (unknown), Firas Kobeissy, Éric Leblanc, Isabelle Fournier, Michel Salzet	19
11	The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response 2021 ·Frontiers in Immunology ·(unknown), Marie Duhamel, Franck Rodet, Michel Salzet	18
12	Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages 2021 ·Cancer Gene Therapy ·(unknown), Marie Duhamel, Soulaimane Aboulouard, Firas Kobeissy, Dominique Tierny, Isabelle Fournier, Franck Rodet, Michel Salzet	12
13	Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro 2020 ·Journal of Extracellular Vesicles ·Adriana‐Natalia Murgoci, Marie Duhamel, Antonella Raffo‐Romero, Khalil Mallah, Soulaimane Aboulouard, Christophe Lefebvre, Firas Kobeissy, Isabelle Fournier, Monika Žilková, Denisa Máderová, Milan Čížek, (unknown), Michel Salzet	25
14	Reference and Ghost Proteins Identification in Rat C6 Glioma Extracellular Vesicles 2020 ·iScience ·Adriana‐Natalia Murgoci, Tristan Cardon, Soulaimane Aboulouard, Marie Duhamel, Isabelle Fournier, (unknown), Michel Salzet	16
15	The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth 2020 ·Molecular Therapy — Oncolytics ·(unknown), Marie Duhamel, Soulaimane Aboulouard, Firas Kobeissy, Emilie Le Guen, Annie Desmons, Dominique Tierny, Isabelle Fournier, Franck Rodet, Michel Salzet	15
16	Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies 2018 ·Molecular & Cellular Proteomics ·Marie Duhamel, (unknown), Franck Rodet, Adriana‐Natalia Murgoci, (unknown), Anne Régnier‐Vigouroux, Fabien Vanden Abeele, Firas Kobeissy, Serge Nataf, Laurent Pays, Maxence Wisztorski, (unknown), Isabelle Fournier, Michel Salzet	21
17	Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy 2018 ·Journal of Biotechnology ·Franck Rodet, (unknown), (unknown), (unknown), Marie Duhamel, (unknown), Antonella Raffo‐Romero, Isabelle Fournier, Michel Salzet	4
18	Real time and in vivo pharmaceutical and environmental studies with SpiderMass instrument 2018 ·Journal of Biotechnology ·Benoit Fatou, Philippe Saudemont, Marie Duhamel, Michaël Ziskind, Cristian Focşa, Michel Salzet, Isabelle Fournier	14
19	The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways 2016 ·Scientific Reports ·Marie Duhamel, Franck Rodet, Adriana‐Natalia Murgoci, Roxane Desjardins, Hugo Gagnon, Maxence Wisztorski, Isabelle Fournier, Robert Day, Michel Salzet	13
20	Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study 2015 ·Molecular & Cellular Proteomics ·Marie Duhamel, Franck Rodet, Nadira Delhem, Fabien Vanden Abeele, Firas Kobeissy, Serge Nataf, Laurent Pays, (unknown), Hugo Gagnon, Maxence Wisztorski, Isabelle Fournier, Robert Day, Michel Salzet	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact